Nasdaq

AnPac Bio Receives Additional Nasdaq Warning Regarding Listing Requirement

AnPac Bio Warned by Nasdaq Over Listing Requirement

Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September

Hong Kong-Based Prenetics to go Public via SPAC

360Dx Index Declines 4 Percent in February, Ending Streak of Gains

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring

Fulgent Genetics, Genetron Pace Stock Price Increases as 360Dx Index Rises 10 Percent to Start 2021

Lucira Health Files for $115M IPO

Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent

360Dx Index Jumps 31 Percent in 2020 as COVID-19 Shifts Attention to Dx Industry

Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December

Veracyte, Quotient Limited Lead Gainers as 360Dx Index Inches Up 1 Percent in November

CareDx, Burning Rock Biotech Pace Gainers as 360Dx Index Rises 6 Percent in October

Diagnostic Firms' Stocks Continue Rollercoaster Ride as 360Dx Index Bounces Back 5 Percent

Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests

Opko Health, Veracyte Pace Gainers as 360Dx Index Grows 13 Percent in July

Piper Sandler Initiates Coverage of Progenity With Overweight Rating

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June